Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve, James C. Patti, Jeffrey Hsu, Thomas Davis, Deborah Dele‐Oni, Peter P. Du, Aya Halawi, Jeffrey J. Ishizuka, Sarah Kim, Susan Klaeger, Nelson H. Knudsen, Brian C. Miller, Tung H. Nguyen, Kira E. Olander, Malvina Papanastasiou, Suzanna Rachimi, Emily Robitschek, Emily M. Schneider, Mitchell D. Yeary, Margaret D. Zimmer, Jacob D. Jaffe, Steven A. Carr, John G. Doench, W. Nicholas Haining, Kathleen B. Yates, Robert T. Manguso, B Bernstein
Topics & Concepts
BiologyEpigeneticsImmune checkpointImmune systemChromatinImmunogenicityCancer researchCell biologyCytotoxic T cellCRISPRGeneticsImmunotherapyGeneIn vitroEpigenetics and DNA MethylationRNA modifications and cancerCRISPR and Genetic Engineering